Clinical Trial Update: Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial [Phase 3]

View source ↗

Summary

A Phase 3 proposed therapeutic trial evaluating levamisole and isoprinosine for COVID-19/respiratory tract infections is listed with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infection

Drugs mentioned

• Isoprinosine (inosine pranobex)
• Levamisole (levamisole)

Snippet

Sponsor: Cairo University | Conditions: Respiratory Tract Infections | Phase 3 | Status: UNKNOWN